1. Potential of Natural Products in the Treatment of Glioma: Focus on Molecular Mechanisms
   Amirhossein Sheida et al, 2024, Cell Biochemistry and Biophysics CrossRef
2. A bird’s eye view of mitochondrial unfolded protein response in cancer: mechanisms, progression and further applications
   Xinyu Zhang et al, 2024, Cell Death & Disease CrossRef
3. Curcumin and 2-DG synergistically target the glio-oncogenesis trigger IL-6 and down-regulate the stemness in glioblastoma model in-vitro
   Kavita Peter et al, 2024, Advances in Traditional Medicine CrossRef
4. Review on the Therapeutic Potential of Curcumin and its Derivatives on Glioma Biology
   Malihe Mohamadian et al, 2022, Neurochemical Research CrossRef
5. Discovering the Protective Effects of Quercetin on Aflatoxin B1-Induced Toxicity in Bovine Foetal Hepatocyte-Derived Cells (BFH12)
   Marianna Pauletto et al, 2023, Toxins CrossRef
6. Research Progress of Curcumin in the Treatment of Glioma
   阳 范, 2024, Advances in Clinical Medicine CrossRef
7. Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
   Yang Xun et al, 2021, Journal of Hematology & Oncology CrossRef
8. The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma
   Pengfei Shi et al, 2023, International Journal of Molecular Sciences CrossRef
9. Biomedical Promise of Sustainable Microwave-Engineered Symmetric Curcumin Derivatives
   Cristina Doina Niţu et al, 2024, Pharmaceutics CrossRef
10. Hsp60 and nervous system development and diseases
    Federica Scalia et al, 2025, The multitasking molecular chaperone Hsp60 CrossRef
11. The multiple roles and therapeutic potential of HSP60 in cancer
    Yaoxiang Tang et al, 2022, Biochemical Pharmacology CrossRef
12. Targeting Glioma Cells with Nutraceuticals: Therapeutic Effects Based on Molecular Mechanisms, New Evidence and Perspectives
    Marziyeh Salami et al, 2023, Mini-Reviews in Medicinal Chemistry CrossRef
13. Enhanced levels of fractalkine and HSP60 in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients
    Rashmi Savant et al, 2024, International Journal of Neuroscience CrossRef
14. Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas
    Xin Tang et al, 2022, Cells CrossRef